Nilotinib (Tasigna (R)) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

Ottmann, Oliver G. and Pfeifer, Heike and Cayuela, Jean-Michel and Spiekermann, Karsten and Jung, Wolfram and Beck, Joachim and Raffoux, Emmanuel and Turlure, Pascal and Himberlin, Chantal and Huguet, Francoise and Viardot, Andreas and Wendelin, Knut and Reichle, Albrecht and Maury, Sebastien and Sanhes, Laurence and Isnard, Francoise and Cahn, Jean-Yves and Lepretre, Stephane and Chevallier, Patrice and Escoffre-Barbe, Martine and Ribera, Josep-Maria and Hoelzer, Dieter and Goekbuget, Nicola and Dombret, Herve and Rousselot, Philippe (2018) Nilotinib (Tasigna (R)) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1-Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02). BLOOD, 132 (Suppl1): 31. ISSN 0006-4971, 1528-0020

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 21 Apr 2020 07:59
Last Modified: 21 Apr 2020 07:59
URI: https://pred.uni-regensburg.de/id/eprint/13501

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.